P - Caution when used during pregnancy
L - Caution when used during Lactation
Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis.
Bacitracin prevents transfer of mucopeptides into the growing cell wall thus inhibiting bacterial cell wall synthesis.
Duration: 6-8 hr.
Absorption: Not well absorbed from the GI tract.
Excretion: About 10-40% of a single injected dose is excreted in the urine within 24 hr.
In Vancomycin-resistant enterococci infections (orally), in Clostridium difficile-associated diarrhoea and colitis (orally), in Staphylococcal infections (i.m) and in Local infections (topical/cutaneous).
Systemic admin: Nausea, vomiting, hypersensitivity reactions, severe nephrotoxicity, inj site pain.
Information Not Available
Pregnancy, lactation, Avoid prolonged use. IM use may cause renal failure. Do not admin IV (severe thrombophloebitis)
Increased risk of nephrotoxicity when used with other nephrotoxic drugs. May enhance the action of neuromuscular-blocking agents.
Information Not Available
Oral
Vancomycin-resistant enterococci infections
Adult: 20,000-25,000 u every 6 hr for 7-10 days.
Oral
Clostridium difficile-associated diarrhoea and colitis
Adult: 20,000-25,000 u every 6 hr for 7-10 days.
Intramuscular
Staphylococcal infections
Adult: 10,000-25,000 u every 6 hr. Max: 100,000 u/day and 25,000 u/dose.
Child: Infant >2.5 kg: 1000 u/kg daily in 2-3 div doses; <2.5 kg: 900 u/kg daily in 2 or 3 div doses. Do not admin for >12 days.
Topical/Cutaneous
Local infections
Adult: In combination with neomycin: Apply once or thrice daily, as directed.
Incompatibility: Incompatible in bases containing stearyl alcohol, cholesterol, polyoxyethylene derivatives and sodium laurilsulfate. Rapidly inactivated in bases containing water, macrogols, propylene glycol, glycerol, cetylpyridinium chloride, benzalkonium chloride, ichthammol, phenol and tannic acid.
Information Not Available
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Caution when used during Lactation
Information Not Available
Information Not Available
Hypersensitivity; renal impairment
Information Not Available
Information Not Available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.